AEE vs REGN · P/E 20, rev $7.62B vs P/E 14, rev $14.34B
Ameren Corp (AEE) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Ameren Corp (AEE) is a utilities - regulated electric company listed on NYSE.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported AEE revenue for 2024-12-31 was $7.62B. Net income was $1.19B. Revenue was up 1.6% from 2023-12-31 to 2024-12-31. AEE currently screens at market cap $30.14B and trailing P/E 19.6.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
AEE currently screens at market cap $30.14B and trailing P/E 19.6. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the AEE and REGN stock pages for the full models.
Not investment advice.